Market Rally Aims for “Cloud Nine,” Bronfman'...

FCC Chairman Brendan Carr joins to discuss SpaceX acquiring a nationwide spectrum portfolio as Starlink looks to take on traditional carriers. Then, Apollo Chief Economist Torsten Slok joins with his expectations for the market. Plus, we bring you a report from Macao about why ga ...  Show more

The White House announces a committee to investigate allegations that Fed Governor Lisa Cook made false statements. Plus, new financial figures from OpenAI spark concerns about AI revenue growth and what it means for the broader AI ecosystem. And Delta slashes its outlook amid so ...  Show more

Shares in Eli Lilly surged on Friday  after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ...  Show more

Stocks jumping to start the week, as investors hope President Trump may be softening his stance on tariffs. If you can believe the bounce, and the sectors seeing the biggest gains. Plus One pharma company looking to tip the scales in the weight loss drug space. What the CEO of ...

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...

Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is fa ...